AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Rejuvenation Technologies secures investment from Jetstream Venture Fund. The amount of the investment was not disclosed.
Round Type
Venture
Mountain ViewBiotechnologyHealth CareTherapeuticsInvestors
Description
Rejuvenation Technologies, a Mountain View, CA-based provider of targeted mRNA therapies, received an investment from Jetstream Venture Fund. The company intends to use the funds to expand operations and enhance R&D efforts. Led by CEO John Ramunas, Rejuvenation Technologies develops therapies aimed at reversing cellular aging. Their platform targets severe age-related diseases through innovative mRNA delivery.
Fundz sees it the moment Rejuvenation Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Rejuvenation Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.